Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products
The Food and Drug Administration announced it will require manufacturers of over-the-counter (OTC) pain relievers, fever reducers and other cough and cold medications that contain non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (the active ingredient in Advil, Motrin and other Brands), aspirin (Bayer Aspirin and other Brands) and naproxen (the active ingredient in Aleve and other Brands) to revise their labeling to include warnings about potential safety risks, such as internal bleeding, associated with the use of these popular drugs. For more information, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm153331.htm
Learn More

New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products
The Food and Drug Administration announced it will require manufacturers of over-the-counter (OTC) pain relievers, fever reducers, and cough and cold medications that contain non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen (the active ingredient in Aleve and other Brands), ibuprofen (the active ingredient in Advil, Motrin and other Brands), and aspirin (Bayer Aspirin and other Brands) to revise their labeling to include warnings about potential safety risks, such as internal bleeding, associated with the use of these popular drugs. For more information, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm153331.htm
Learn More

Date Published Title Drug Source
2009-05-04 New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products FDA
2009-05-04 New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products FDA
2009-05-05 New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products Hydrocodone Bitartrate with Ibuprofen FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Carbamazepine FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Felbamate FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Gabapentin FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Lamotrigine FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Levetiracetam FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Oxcarbazepine FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Pregabalin FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Tiagabine FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Topiramate FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Divalproex Sodium FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Zonisamide FDA
2009-05-06 FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers FDA
2009-05-07 Boxed Warning Added to Testosterone Gel Products (Androgel, Testim) Testosterone FDA
2009-05-09 UPDATE: Nationwide Recall of Hydroxycut-Branded Products Hydroxycut FDA
2009-05-09 UPDATE: Nationwide Recall of Hydroxycut-Branded Products Hydroxycut Ephedra Free FDA
2009-05-09 New Warnings Added to the Labeling of Tarceva Erlotinib FDA
2009-05-13 National Recall on A S Medication Solutions Digoxin Digoxin FDA